"attention deficit hyperactivity disorder"

Digital technologies for assessing attention deficit hyperactivity disorder (ADHD) Digital technologies for assessing attention deficit hyperactivity disorder (ADHD) Diagnostics guidance Published: 21 October 2024 www.nice.org.uk/guidance/dg60 © NICE 2024. All rights reserved. Subject to Notice of rights ( responsibility This guidance represents the view of NICE, arrived at after careful . Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Digital technologies for assessing attention deficit hyperactivity disorder (ADHD) (DG60)© NICE 2024. All rights reserved. Subject to Notice of rights ( 2 of22 Contents 1 Recommendations

QbTest for the assessment of attention deficit hyperactivity disorder (ADHD) QbTest for the assessment of attention deficit hyperactivity disorder (ADHD) Medtech innovation briefing Published: 7 March 2023 www.nice.org.uk/guidance/mib318 Summary • The technology described in this briefing is QbTest. It is used to help assess attention deficit hyperactivity disorder (ADHD) and to evaluate that the potential benefits were quicker assessment, and cost savings because of clinician time saving and efficiency of the pathway. • The cost of QbTest is £23 to £96 per assessment (excluding VAT). There is some evidence of cost reduction as well as return on investment. The technology QbTest (Qbtech Ltd) can be used to aid the assessment of attention deficit hyperactivity disorder (ADHD) and for evaluating

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed and treated psychiatric disorders in childhood. Typically, children and adolescents with ADHD find it difficult to pay attention and they are hyperactive and impulsive. Methylphenidate is the psychostimulant most often prescribed, but the evidence on benefits and harms is uncertain. This is an update of our comprehensive systematic review on benefits and harms published in 2015. To assess the beneficial and harmful effects of methylphenidate for children and adolescents with ADHD. We searched CENTRAL, MEDLINE, Embase, three other databases and two trials registers up to March 2022. In addition, we checked

Psychosocial interventions in youth aged under 18 with attention-deficit/hyperactivity disorder (ADHD) Psychosocial interventions in youth aged under 18 with attention-deficit/hyperactivity disorder (ADHD) English summary Une production de l’Institut national d’excellence en santé et en services sociaux (INESSS) NOVEMBER 2024 1 SUMMARY Psychosocial interventions in youth aged under 18 with attention-deficit/hyperactivity disorder (ADHD) Introduction Attention-deficit/hyperactivity disorder (ADHD) is a persistent pattern of inattention and/or hyperactivity-impulsivity. It is a common neurodevelopmental disorder that interferes with functioning or development and evolves over one’s life course. The prevalence of ADHD is higher in Quebec compared to other Canadian provinces. Moreover, since

Care Management for Youth under 18 with Attention Deficit Hyperactivity Disorder (ADHD) Care Management for Youth under 18 with Attention Deficit Hyperactivity Disorder (ADHD) - Report in Support of the Care Management Tool Summary Une production de l’Institut national d’excellence en santé et en services sociaux (INESSS) NOVEMBER 2024 1 SUMMARY Care Management for Youth under 18 with Attention Deficit Hyperactivity Disorder (ADHD) - Report in Support of the Care Management Tool Attention deficit disorder with or without hyperactivity (ADHD) is a neurodevelopmental disorder with a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with a person's functioning or development. A worrying increase in the number of ADHD diagnoses and associated medication

Attention deficit hyperactivity disorder (ADHD) in adults with intellectual disability Open submenu ( Become a psychiatrist )Become a psychiatristOpen submenu ( Training )TrainingOpen submenu ( Members )MembersOpen submenu ( Events )EventsOpen submenu ( Improving care )Improving careOpen submenu ( Mental health )Mental healthABOUT THE COLLEGENEWS AND FEATURESINTERNATIONALThis site uses cookies : Find out moreOkay, thanksSKIP NAVIGATION LOGIN DONATE SEARCHMenu   HomeImproving careCampaigning for better mental health policyCollege Reports2021 College ReportsAttention deficit hyperactivity disorder (ADHD) in adults with intellectual disability (CR230)Attention deficit hyperactivity disorder (ADHD) in adults with intellectual disability CR230, February 2021This Report is in support

Lisdexamfetamine for attention deficit hyperactivity disorder (ADHD)

Attention deficit hyperactivity disorder in children

Attention deficit hyperactivity disorder in adults

/hyperactivity disorder (ADHD) using responder analyses of the Brown Attention-Deficit Disorder Scale (BADDS). Post hoc analyses examined data from placebo-controlled SHP465 MAS dose-optimization (12.5-75 mg) and fixed-dose (25-75 mg) studies. Treatment response was assessed using two definitions (BADDS total score at endpoint <50 [no EF impairment] vs. ≥50 [impaired]; BADDS total score at endpoint relative Improved Executive Function in Adults Diagnosed With Attention-Deficit/ Hyperactivity Disorder as Measured by the Brown Attention-Deficit Disorder Scale Following Treatment With SHP465 Mixed Amphetamine Salts Extended-Release: Post Hoc Analyses From 2 Ra Assess executive function (EF) improvement with SHP465 mixed amphetamine salts (MAS) extended-release in adults with attention-deficit

Coping strategies and symptoms of Adjustment Disorder among adults with Attention Deficit Hyperactivity Disorder (ADHD) during the Covid-19 pandemic. The current study examined whether coping strategies and symptoms of Adjustment Disorder in adults with ADHD differed from what was observed in the general adult population during the Covid-19 pandemic, and compared the extent to which coping strategies and symptom levels of Adjustment Disorder were related to ADHD. This cross-sectional study was based on survey data collected during the spring of 2021 from 231 adult ADHD patients in specialist care and 1148 volunteers without ADHD in Sweden. The survey included questions about sociodemographic and clinical characteristics, along with the Brief-COPE and Adjustment Disorder-New Module 8

English Summary - Optimal service trajectory for children, adolescents and young adults with attention deficit disorder with or without hyperactivity (ADHD) or related problems 1 Optimal service trajectory for children, adolescents and young adults with attention deficit disorder with or without hyperactivity (ADHD) or related problems English summary MARCH 2018 Une production de l’Institut work led to the identification of certain deficiencies in the patient service trajectory in Québec, with regard both to pharmacological and psychosocial interventions. This report on the optimal service trajectory for children, adolescents and young adults with attention deficit disorder with or without hyperactivity (ADHD) or related problems proposes guiding principles and recommendations developed

Attention-Deficit/Hyperactivity Disorder Medications for Adults View of Attention-Deficit/Hyperactivity Disorder Medications for Adults | Canadian Journal of Health Technologies Return to Article DetailsAttention-Deficit/Hyperactivity Disorder Medications for Adults

Efficacy of internet-based cognitive behavioral therapy for medicated adults with attention-deficit/hyperactivity disorder (ADHD): A randomized controlled trial. Cognitive behavioral therapy (CBT) is an effective treatment for adults with attention-deficit/hyperactivity disorder (ADHD), but its use is limited by poor accessibility and time constraints-barriers that internet-based CBT (iCBT) may help overcome. This trial aimed to explore the short- and long-term efficacy of iCBT in medicated adults with ADHD. Eighty-six adults with ADHD were randomized into two groups: the iCBT combined with medication group (iCBT+M, n = 43) and the medication-only group (n = 43). The iCBT+M group received 12 weeks of iCBT with ongoing medication, while the medication-only group continued with medication

Clinical symptoms and functional impairment in attention deficit hyperactivity disorder (ADHD) co-morbid tic disorder (TD) patients: a cluster-based investigation. Attention deficit hyperactivity disorder (ADHD) and tic disorder (TD) are two common neurodevelopmental disorders that frequently occur in childhood, and these two disorders often coexist. Cluster analysis provides a novel perspective on the heterogeneity of these commonly observed clinical disorders. We recruited patients with comorbid ADHD and TD from Beijing Children's Hospital between May 2022 and August 2023, collecting data on their symptoms and functional impairments. The number of clusters was determined using the elbow method, and K-means clustering was conducted. Fisher discriminant analysis and silhouette score were used for validation

Socioeconomic disparities in attention deficit hyperactivity disorder (ADHD) in Sweden: An intersectional ecological niches analysis of individual heterogeneity and discriminatory accuracy (IEN-AIHDA). We aimed (i) to gain a better understanding of the demographic and socioeconomical distribution of ADHD risk in Sweden; and (ii) to contribute to the critical discussion on medicalization, i.e ., the tendency to define and treat behavioural and social problems as medical entities. For this purpose, we analysed the risk of suffering from ADHD in the whole Swedish population aged between 5 and 60 years, across 96 different strata defined by combining categories of gender, age, income, and country of birth. The stratified analysis evidenced considerable risk heterogeneity, with prevalence values ranging

Internet addiction and its relationship with attention deficit hyperactivity disorder (ADHD) symptoms, anxiety and stress among university students in Malaysia. There is growing evidence on the contribution of psychological factors to internet addiction; yet it remains inconsistent and deserves further exploration. The aim of this study was to determine the relationship between the psychological symptoms (Attention Deficit Hyperactivity Disorder (ADHD) symptoms, stress, depression, anxiety and loneliness) and internet addiction (IA) among the university students in Malaysia. A total of 480 students from different faculties in a Malaysian public university participated in this study. They were selected by simple random sampling method. They completed self-administered questionnaires including

Attention Deficit Hyperactivity Disorder (ADHD) and the gut microbiome: An ecological perspective. Attention Deficit Hyperactivity Disorder (ADHD) is an increasingly prevalent neuropsychiatric disorder characterized by hyperactivity, inattention, and impulsivity. Symptoms emerge from underlying deficiencies in neurocircuitry, and recent research has suggested a role played by the gut microbiome . The gut microbiome is an ecosystem of interdependent taxa involved in an exponentially complex web of interactions, plus host gene and reaction pathways, some of which involve neurotransmitters with roles in ADHD neurocircuitry. Studies have analyzed the ADHD gut microbiome using macroscale metrics such as diversity and differential abundance, and have proposed several taxa as elevated or reduced

Attention-deficit/hyperactivity disorder (ADHD) in cultural context II: a comparison of the links between ADHD symptoms and waiting-related responses in Hong Kong and UK. The concept of attention-deficit/hyperactivity disorder (ADHD) is considered to have cross-cultural validity, but direct comparisons of its psychological characteristics across cultures are limited. This study investigates whether preschool children's ADHD symptoms expressed in two cultures with different views about child behaviour and parenting, Hong Kong and the UK, show the same pattern of associations with their waiting-related abilities and reactions, an important marker of early self-regulation. A community sample of 112 preschoolers (mean age = 46.22 months; 55 from UK, 57 from HK) completed three tasks measuring

Attention deficit hyperactivity disorder CKS is only available in the UK | NICE CKS is only available in the UKThe NICE Clinical Knowledge Summaries (CKS) site is only available to users in the UK, Crown Dependencies and British Overseas Territories.CKS content is produced by Clarity Informatics Limited. It is available to users outside the UK via subscription from the Prodigy website.If you